Primary Recipient

AMBERGEN, INC

Amount

$399,000.00

Award Date

9/25/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

This overall parent project aims to develop a new, highly sensitive, mutation scanning technology for the molecular analysis of cancer. While broadly applicable in oncology, the initial commercial product which is the focus of the parent Phase II SBIR pro